Hill-Rom Holdings (HRC +3%) moves up on an upgrade to Conviction-Buy at Goldman Sachs. Goldman says the hospital bed cycle has bottomed and they see potential for a rebound in the second half. The firm adds that FQ1 results were solid, and cash flow growth should support higher levels of share repurchases. The firm raises its price target on the stock to $41 from $40.
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs